UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults

Cochrane database of systematic reviews, 2017-08, Vol.8 (9), p.CD012763

2017

Volltextzugriff (PDF)

Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Complications (STRONGER): A Multicenter Matched Cohort Analysis

Anesthesiology (Philadelphia), 2020-06, Vol.132 (6), p.1371-1381

2020

Volltextzugriff (PDF)

Diagnosis and Management of Dementia: Review

JAMA : the journal of the American Medical Association, 2019-10, Vol.322 (16), p.1589

2019

Volltextzugriff (PDF)

An update on the utility and safety of cholinesterase inhibitors for the treatment of Alzheimer's disease

Expert opinion on drug safety, 2020-02, Vol.19 (2), p.147-157

2020

Volltextzugriff (PDF)

Rivastigmine for gait stability in patients with Parkinson's disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial

Lancet neurology, 2016-03, Vol.15 (3), p.249-258

2016

Volltextzugriff (PDF)

Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease: Three Randomized Clinical Trials

JAMA : the journal of the American Medical Association, 2018-01, Vol.319 (2), p.130

2018

Volltextzugriff (PDF)

Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease

The New England journal of medicine, 2012-03, Vol.366 (10), p.893-903

2012

Volltextzugriff (PDF)

Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis

Cochrane database of systematic reviews, 2021-02, Vol.2 (2), p.CD013306

2021

Volltextzugriff (PDF)

Adverse Effects of Cholinesterase Inhibitors in Dementia, According to the Pharmacovigilance Databases of the United-States and Canada

PloS one, 2015-12, Vol.10 (12), p.e0144337

2015

Volltextzugriff (PDF)

Effect of acetylcholinesterase inhibitors on post-stroke cognitive impairment and vascular dementia: A meta-analysis

PloS one, 2020-02, Vol.15 (2), p.e0227820-e0227820

2020

Volltextzugriff (PDF)

Rivastigmine for Alzheimer's disease

Cochrane database of systematic reviews, 2015-04 (4), p.CD001191

2015

Volltextzugriff (PDF)

Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis

Journal of neurology, neurosurgery and psychiatry, 2015-02, Vol.86 (2), p.135-143

2015

Volltextzugriff (PDF)

TV 3326 for Alzheimer’s dementia: a novel multimodal ChE and MAO inhibitors to mitigate Alzheimer’s‐like neuropathology

Journal of pharmacy and pharmacology, 2020-08, Vol.72 (8), p.1001-1012

2020

Volltextzugriff (PDF)

Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials

Journal of clinical anesthesia, 2016-12, Vol.35, p.1-12

2016

Volltextzugriff (PDF)

Multifunctional tacrine–trolox hybrids for the treatment of Alzheimer's disease with cholinergic, antioxidant, neuroprotective and hepatoprotective properties

European journal of medicinal chemistry, 2015-03, Vol.93, p.42-50

2015

Volltextzugriff (PDF)

Outcomes of Alzheimer's disease therapy with acetylcholinesterase inhibitors and memantine

Expert opinion on drug safety, 2014-06, Vol.13 (6), p.759-774

2014

Volltextzugriff (PDF)

Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial

The Lancet (British edition), 2010-11, Vol.376 (9755), p.1829-1837

2010

Volltextzugriff (PDF)

Pharmacological management of anticholinergic delirium ‐ theory, evidence and practice

British journal of clinical pharmacology, 2016-03, Vol.81 (3), p.516-524

2016

Volltextzugriff (PDF)

Comparison of incidence of anaphylaxis between sugammadex and neostigmine: a retrospective multicentre observational study

British journal of anaesthesia : BJA, 2020-02, Vol.124 (2), p.154-163

2020

Volltextzugriff (PDF)

Anticholinergic Activity of 107 Medications Commonly Used by Older Adults

Journal of the American Geriatrics Society (JAGS), 2008-07, Vol.56 (7), p.1333-1341

2008

Volltextzugriff (PDF)

Acetylcholinesterase inhibitors for autistic spectrum disorders

Cochrane database of systematic reviews, 2023-06, Vol.6 (6), p.CD013851-CD013851

2023

Volltextzugriff (PDF)

A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer's disease

Journal of Alzheimer's disease, 2013-01, Vol.35 (2), p.349-361

2013

Volltextzugriff (PDF)

Dose-dependent Association between Intermediate-acting Neuromuscular-blocking Agents and Postoperative Respiratory Complications

Anesthesiology (Philadelphia), 2015-06, Vol.122 (6), p.1201-1213

2015

Volltextzugriff (PDF)

Comparative safety and effectiveness of cholinesterase inhibitors and memantine for Alzheimer's disease: a network meta-analysis of 41 randomized controlled trials

Alzheimer's research & therapy, 2018-12, Vol.10 (1), p.126-126, Article 126

2018

Volltextzugriff (PDF)

The efficacy and safety of memantine for the treatment of Alzheimer's disease

Expert opinion on drug safety, 2018-10, Vol.17 (10), p.1053-1061

2018

Volltextzugriff (PDF)

1 – 25 von 2.321

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.969)
Mit Volltextzugriff
(1.546)

Publikationsform

Sprache

14 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(2.048)
Science & Technology
(1.739)
Life Sciences & Biomedicine
(1.716)
Cholinesterase Inhibitors - Adverse Effects
(1.419)
Male
(1.057)
Cholinesterase Inhibitors - Therapeutic Use
(993)
Female
(978)
Aged
(804)
Alzheimer Disease - Drug Therapy
(674)
Biological And Medical Sciences
(596)
Medical Sciences
(566)
Middle Aged
(522)
Pharmacology & Pharmacy
(448)
Animals
(427)
Adult
(423)
Cholinesterase Inhibitors - Administration & Dosage
(407)
Neurosciences & Neurology
(389)
Alzheimer's Disease
(375)
Treatment Outcome
(365)
Aged, 80 And Over
(360)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults

Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Complications (STRONGER): A Multicenter Matched Cohort Analysis

Diagnosis and Management of Dementia: Review

An update on the utility and safety of cholinesterase inhibitors for the treatment of Alzheimer's disease

Rivastigmine for gait stability in patients with Parkinson's disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial

Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease: Three Randomized Clinical Trials

Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease

Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis

Adverse Effects of Cholinesterase Inhibitors in Dementia, According to the Pharmacovigilance Databases of the United-States and Canada

Effect of acetylcholinesterase inhibitors on post-stroke cognitive impairment and vascular dementia: A meta-analysis

Rivastigmine for Alzheimer's disease

Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis

TV 3326 for Alzheimer’s dementia: a novel multimodal ChE and MAO inhibitors to mitigate Alzheimer’s‐like neuropathology

Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials

Multifunctional tacrine–trolox hybrids for the treatment of Alzheimer's disease with cholinergic, antioxidant, neuroprotective and hepatoprotective properties

Outcomes of Alzheimer's disease therapy with acetylcholinesterase inhibitors and memantine

Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial

Pharmacological management of anticholinergic delirium ‐ theory, evidence and practice

Comparison of incidence of anaphylaxis between sugammadex and neostigmine: a retrospective multicentre observational study

Anticholinergic Activity of 107 Medications Commonly Used by Older Adults

Acetylcholinesterase inhibitors for autistic spectrum disorders

A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer's disease

Dose-dependent Association between Intermediate-acting Neuromuscular-blocking Agents and Postoperative Respiratory Complications

Comparative safety and effectiveness of cholinesterase inhibitors and memantine for Alzheimer's disease: a network meta-analysis of 41 randomized controlled trials

The efficacy and safety of memantine for the treatment of Alzheimer's disease

Suchergebnisse filtern